{
    "Trade/Device Name(s)": [
        "cobas\u00ae CT/NG v2.0 Test",
        "cobas\u00ae PCR Media Dual Swab Sample Kit",
        "cobas\u00ae PCR Urine Sample Kit"
    ],
    "Submitter Information": "Roche Molecular Systems, Inc.",
    "510(k) Number": "K163184",
    "Predicate Device Reference 510(k) Number(s)": [
        "K110923",
        "K132270"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LSL",
        "MKZ",
        "OOI"
    ],
    "Summary Letter Date": "March 6, 2017",
    "Summary Letter Received Date": "November 14, 2016",
    "Submission Date": "November 11, 2016",
    "Regulation Number(s)": [
        "21 CFR 866.3390",
        "21 CFR 866.3120"
    ],
    "Regulation Name(s)": [
        "Neisseria spp. Direct serological test reagents",
        "Chlamydia serological reagents"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Chlamydia trachomatis DNA",
        "Neisseria gonorrhoeae DNA"
    ],
    "Specimen Type(s)": [
        "Male urine",
        "Female urine",
        "Self-collected vaginal swab",
        "Clinician-collected vaginal swab",
        "Endocervical swab",
        "Cervical specimen"
    ],
    "Specimen Container(s)": [
        "cobas\u00ae PCR Media Dual Swab Sample Kit",
        "cobas\u00ae PCR Urine Sample Kit",
        "PreservCyt\u00ae solution"
    ],
    "Instrument(s)/Platform(s)": [
        "cobas\u00ae 4800 platform"
    ],
    "Method(s)/Technology(ies)": [
        "Polymerase Chain Reaction (PCR)",
        "Nucleic acid amplification"
    ],
    "Methodologies": [
        "Qualitative nucleic acid amplification testing"
    ],
    "Submission Type(s)": [
        "Assay",
        "Specimen collection device",
        "Transport medium",
        "Extraction kit"
    ],
    "Document Summary": "FDA 510(k) summary for cobas\u00ae CT/NG v2.0 Test and associated specimen collection kits for PCR-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae DNA in urogenital specimens",
    "Indications for Use Summary": "Automated in vitro qualitative PCR test for detecting Chlamydia trachomatis and Neisseria gonorrhoeae DNA in urine and various swab specimens, intended as an aid in diagnosis of chlamydial and gonococcal disease in symptomatic and asymptomatic individuals",
    "fda_folder": "Microbiology"
}